Article
Prostate Power Play: Does Pik3ca Accelerate Pten -Deficient Cancer Progression?
31 May 2018
Abstract excerpt
Abstract Summary: PI3K pathway alterations are frequently recurrent in metastatic prostate cancer and are associated with the development of currently incurable castration-resistant disease. Candidate inhibitors that target single PI3K pathway members lack efficacy as demonstrated in multiple clinical trials. In this issue, Pearson and colleagues examine the functional importance of co-occurring PIK3CA and PTEN...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
